Home > Healthcare > Medical Services > Diagnostic Services > cholesterol testing services market
Get a free sample of Cholesterol Testing Services Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Cholesterol Testing Services Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Cholesterol Testing Services Market was valued at around USD 20.5 billion in 2023 and is estimated to grow at 8.1% CAGR from 2024 to 2032. Cholesterol testing services refer to diagnostic procedures and laboratory testing offered by healthcare providers or clinical laboratories to measure levels of cholesterol in a patient's blood. Cholesterol testing is an essential component of cardiovascular risk assessment and disease prevention. The procedure typically involves collecting a blood sample from the patient, which is then analyzed to determine the levels of various types of cholesterol, including low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides.
Moreover, increasing use of cardiac arrhythmia monitoring devices, rising adoption of cardiology information system (market size is estimated to account for USD 2.4 billion by the end of year 2032), growing awareness about prediabetes, rising healthcare expenditure globally, government initiatives and funding, and increasing education & awareness, are the stimulating factors fostering the growth of the market.
Abbott Laboratories, Accu Reference Medical Lab, LLC, Atherotech Diagnostics Lab, Bio-Reference Laboratories, Inc., Boston Heart Diagnostics Corporation, Cell Biolabs Inc., Clinical Reference Laboratory, Inc., Eurofins Scientific, Mayo Clinic Laboratories, and Quest Diagnostics Incorporated
U.S. cholesterol testing services market is anticipated to grow at 7.8% CAGR during 2024 to 2032, attributed to the rising prevalence of cardiovascular diseases.
The total cholesterol tests segment in the total cholesterol testing services market will generate USD 14.4 billion by 2032, driven by the comprehensive measure of the total amount of cholesterol present in the blood.
The market valuation of cholesterol testing services was reached USD 20.5 billion in 2023 and is estimated to grow at 8.1% CAGR from 2024 to 2032, owing to the growing awareness of preventive healthcare.